Psychiatric Disorders Related to Diabetes Mellitus Type 1

Diabetes Mellitus Type 1 Clinical Trial

Official title:

Psychiatric Disorders Related to Diabetes Mellitus Type 1 Among Adolescents in Egypt

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05477433
• Other study ID #: diabetes mellitus
• Status: Not yet recruiting
• Start date: August 1, 2022
• Est. completion date: December 1, 2025

Study information

• Verified date: July 2022
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The most common endocrine illness in children and adolescents is type 1 diabetes. It is distinguished by a lack of insulin synthesis and necessitates daily insulin injections to keep glucose levels under control. As a result, there are numerous medical approaches to its management, such as levels of glycosylated haemoglobin (HbA1c) as a marker of glycemic control during the previous three months and monitoring of blood glucose levels, which affect the patient's mental health and quality of life. Type 1 diabetes complications and poor quality of life are widespread. Diabetes therapy is difficult during puberty and adolescence. Adolescents with T1D have poor metabolic control and a higher rate of acute complications. Because the onset of adolescence is frequently associated with decreased adherence to therapy and an increased risk of psychological illnesses.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 140
• Est. completion date: December 1, 2025
• Est. primary completion date: December 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 10 Years to 19 Years

Eligibility

Inclusion Criteria:

1. Both males and females were included.

2. Age ranges from 10 to 19 years.

3. Willing of the parents or the caregivers to participate in the study.

4. Duration of T1DM of at least 1 year. Exclusion Criteria

1. Adolescents with an intelligence quotient below 70.

2. Adolescents with a history of substance use or psychiatric disorders.

3. Adolescents with medical or other neurological conditions.

Related Conditions & MeSH terms

• Adolescents
• Diabetes Mellitus
• Diabetes Mellitus Type 1
• Diabetes Mellitus, Type 1
• Mental Disorders
• Problem Behavior
• Psychiatric Disorders

Intervention

Behavioral:
• diabetes mellitus type 1
Pittsburgh Sleep Quality Index "PSQI": It is used to detect sleep disturbance or deficits. The PSQI has a scoring key that can be used to calculate a patient's seven subscores, which range from 0 to 3. The subscores are added together to produce a "global" score that ranges from 0 to 21. A global score of 5 or higher denotes poor sleep quality, The Strengths and Dif?culties Questionnaire (SDQ) The SDQ is a well-validated screening tool for children and adolescents aged 4-17 years that can identify behavioural and emotional issues,Emotional Avoidance Strategy Inventory for Adolescents (EASI) is used. The EASI-A is a 17-item assessing the use of emotionally avoidant strategies in adolescents and higher scores means significants use avoidant strategies, The Toronto Alexithymia Scale (TAS-20) is a self-administered 20-item questionnaire which assesses difficulties in identifying and describing emotions. TAS scores were significantly higher in alexithymia

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measure frequency of sleep problems with diabetes mellitus type 1		through study completion, an average of 1 year
Primary	Measures frequency of psychiatric problems with diabetes mellitus type 1		through study completion, an average of 1 year